Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Aug 12;8(8):e71726.
doi: 10.1371/journal.pone.0071726. eCollection 2013.

Reconstructing the Qo site of Plasmodium falciparum bc 1 complex in the yeast enzyme

Affiliations

Reconstructing the Qo site of Plasmodium falciparum bc 1 complex in the yeast enzyme

Cindy Vallières et al. PLoS One. .

Abstract

The bc 1 complex of the mitochondrial respiratory chain is essential for Plasmodium falciparum proliferation, the causative agent of human malaria. Therefore, this enzyme is an attractive target for antimalarials. However, biochemical investigations of the parasite enzyme needed for the study of new drugs are challenging. In order to facilitate the study of new compounds targeting the enzyme, we are modifying the inhibitor binding sites of the yeast Saccharomyces cerevisiae to generate a complex that mimics the P. falciparum enzyme. In this study we focused on its Qo pocket, the site of atovaquone binding which is a leading antimalarial drug used in treatment and causal prophylaxis. We constructed and studied a series of mutants with modified Qo sites where yeast residues have been replaced by P. falciparum equivalents, or, for comparison, by human equivalents. Mitochondria were prepared from the yeast Plasmodium-like and human-like Qo mutants. We measured the bc 1 complex sensitivity to atovaquone, azoxystrobin, a Qo site targeting fungicide active against P. falciparum and RCQ06, a quinolone-derivative inhibitor of P. falciparum bc 1 complex.The data obtained highlighted variations in the Qo site that could explain the differences in inhibitor sensitivity between yeast, plasmodial and human enzymes. We showed that the yeast Plasmodium-like Qo mutants could be useful and easy-to-use tools for the study of that class of antimalarials.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Sequence and structure of the Qo site.
(A) Comparison of cytochrome b sequence. Regions of the polypeptide forming the Qo domain and its vicinity are shown. The Qo site itself is formed by residues located in the regions 120–150 and 260–280. Mutated residues studied here are highlighted in colour. Green arrows and bars indicate structural components, as shown in panels B and C: C and F1 are transmembrane helices; cd1 and cd2, extramembrane short helices; ef, a loop containing highly conserved residues. Hs, human; Sc, yeast; Pf, Plasmodium falciparum. (B) Location of the mutated residues in the yeast bc 1 Qo site. The figure was drawn using the coordinates of 3CX5.PDB . VLPW, location of the mutation CCVY133–136VLPW. (C) Molecular model of atovaquone (lilac CPK) and RCQ06 (cyan CPK) docked in the Qo site of yeast cytochrome b (3CX5.PDB [39]). Selected sidechains from cytochrome b and the ISP are represented in orange. The alpha carbon backbones of cytochrome b and the ISP are represented in cartoon form in grey/green and dark pink respectively. Helices of interest within cytochrome b forming structural elements of Qo are labelled in green. Also shown are the haem b l and [2Fe2S] prosthetic groups of cytochrome b and the ISP. Residue notation corresponds to the yeast enzyme. Atv, atovaquone.
Figure 2
Figure 2. Chemical structures of atovaquone, azoxystrobin and RCQ06.

Similar articles

Cited by

References

    1. Painter HJ, Morrisey JM, Mather MW, Vaidya AB (2007) Specific role of mitochondrial electron transport in blood-stage Plasmodium falciparum . Nature 446: 88–91. - PubMed
    1. Musset L, Bouchaud O, Matheron S, Massias L, Le Bras J (2006) Clinical atovaquone-proguanil resistance of Plasmodium falciparum associated with cytochrome b codon 268 mutations. Microbes Infect 8: 2599–2604. - PubMed
    1. Musset L, Le Bras J, Clain J (2007) Parallel evolution of adaptive mutations in Plasmodium falciparum mitochondrial DNA during atovaquone-proguanil treatment. Mol Biol Evol 24: 1582–1585. - PubMed
    1. Barton V, Fisher N, Biagini GA, Ward SA, O'Neill P (2010) Inhibiting Plasmodium cytochrome bc 1: a complex issue. Curr Opin Chem Biol 14: 1–7. - PubMed
    1. Biagini GA, Fisher N, Shone AE, Mubaraki MA, Srivastava A, et al. (2012) Generation of quinolone antimalarials targeting the Plasmodium falciparum mitochondrial respiratory chain for the treatment and prophylaxis of malaria. Proc Natl Acad Sci U S A 109: 8298–8303. - PMC - PubMed

Publication types

MeSH terms